David L. Waning, Ph.D.
Affiliations: | Northwestern University, Evanston, IL |
Area:
virologyGoogle:
"David Waning"Mean distance: 13.83 | S | N | B | C | P |
Parents
Sign in to add mentor| Robert A. Lamb | grad student | 2004 | Northwestern | |
| (Functional analysis of the paramyxovirus SV5 fusion protein.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trivedi T, Manaa M, John S, et al. (2023) Zoledronic acid improves bone quality and muscle function in a high bone turnover state. Biorxiv : the Preprint Server For Biology |
| Hain BA, Waning DL. (2022) Bone-Muscle Crosstalk: Musculoskeletal Complications of Chemotherapy. Current Osteoporosis Reports |
| Wilcox-Hagerty JR, Xu H, Hain B, et al. (2022) TGFβ Induces Changes in Mitochondrial Homeostasis in Skeletal Muscle of Mice with Bone Metastases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Hain BA, Xu H, VanCleave AM, et al. (2021) REDD1 deletion attenuates cancer cachexia in mice. Journal of Applied Physiology (Bethesda, Md. : 1985). 131: 1718-1730 |
| Chakraborty N, Waning DL, Gautam A, et al. (2020) Gene-metabolite network linked to inhibited bioenergetics in association with spaceflight-induced loss of male mouse quadriceps muscle. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Hain BA, Jude B, Xu H, et al. (2019) Zoledronic acid improves muscle function in healthy mice treated with chemotherapy. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research |
| Hain BA, Xu H, Wilcox JR, et al. (2019) Chemotherapy-induced loss of bone and muscle mass in a mouse model of breast cancer bone metastases and cachexia. Jcsm Rapid Communications. 2 |
| Huot JR, Essex AL, Gutierrez M, et al. (2019) Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles. Cancers. 11 |
| Sturgeon KM, Mathis KM, Rogers CJ, et al. (2019) Cancer- and Chemotherapy-Induced Musculoskeletal Degradation. Jbmr Plus. 3: e10187 |
| Waning DL, Guise TA, Mohammad KS. (2019) A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone. Cell Metabolism. 29: 6-8 |